Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Generation of an antibody against the protein phosphatase 1 inhibitor KEPI and characterization of the epitope

: Daskalow, K.; Boisguerin, P.; Jandrig, B.; Landeghem, F.K.H. van; Volkmer, R.; Micheel, B.; Schenk, J.A.

Klapdor, R.:
14th International Hamburg Symposium on Tumor Markers 2008. Proceedings : 7 - 9 December 2008, Hamburg, Germany
Attiki: Internat. Inst. of Anticancer Research, 2010 (Anticancer research 30.2010, Nr.5)
ISSN: 0250-7005
International Hamburg Symposium on Tumor Markers <14, 2008, Hamburg>
Konferenzbeitrag, Zeitschriftenaufsatz
Fraunhofer IBMT ()

A monoclonal antibody against the potential tumor suppressor kinase-enhanced protein phosphatase 1 (PP1) inhibitor KEPI (PPP1R14C) was generated and characterized. Human KEPI was expressed in Escherichia coli and used to immunize Balb/c mice. Using hybridoma technology, one clone, G18AF8, was isolated producing antibodies which bound specifically to the KEPI protein in ELISA, immunoblotting and flow cytometry. The antibody was also successfully applied to stain KEPI protein in paraffin sections of human brain. The epitope was mapped using peptide array technology and confirmed as GARVFFQSPR. This corresponds to the N-terminal region of KEPI. Amino acid substitution analysis revealed that two residues, F and Q, are essential for binding. Affinity of binding was determined by competitive ELISA as 1 mu M. In Western blot assays testing G18AF8 antibody on brain samples of several species, reactivity with hamster, rat and chicken samples was found, suggesting a broad homology of this KEPI epitope in vertebrates. This antibody could be used in expression studies at the protein level e.g. in tumor tissues.